From Asterisk Magazine —
GLP-1 medications1 like Ozempic appear to be that drug. Estimates suggest GLP-1s can reduce body weight by at least 15% when taken regularly — and perhaps even more as newer drugs come to market. And though evidence is still being gathered, they may have benefits beyond weight loss: potentially curbing drinking, treating sleep apnea, and reducing risk of stroke. They’ve been called, in many places, a miracle drug, and as such, the category is poised for massive growth. Gallup estimated that 15.5 million Americans have tried them, and half as many are currently using them.
My forecast predicts that the supply of GLP-1s will increase from eight million patient-years to roughly enough for approximately 23 million Americans by 2030. Still, this is only enough supply for about 15% of the 147 million Americans with diabetes or obesity.
Wild. There is definitely some value to these drugs but at what cost over natural measures? For some, I’m sure Ozempic represents a miracle but it’s also a drug that doctors and researchers are still experimenting with and trying to fully understand.
1 thought on “How long until we’re all on Ozempic?”